wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55206226-2BC31F88-8BA8-4E20-827A-4EFECCB2BC6C
Q55206226-2BC31F88-8BA8-4E20-827A-4EFECCB2BC6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55206226-2BC31F88-8BA8-4E20-827A-4EFECCB2BC6C
Extraintestinal Manifestations of Inflammatory Bowel Disease.
P2860
Q55206226-2BC31F88-8BA8-4E20-827A-4EFECCB2BC6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55206226-2BC31F88-8BA8-4E20-827A-4EFECCB2BC6C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb83675d783d75c1d4275d6aac3ff2e8e60a6c54
P2860
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.